Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_assertion type Assertion NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_head.
- NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_assertion wasGeneratedBy ECO_0000203 NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_provenance.
- NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_assertion wasDerivedFrom befree-2016 NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_provenance.
- NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_assertion SIO_000772 10849534 NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_provenance.
- NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_assertion evidence source_evidence_literature NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_provenance.
- NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_assertion description "[We determined prospectively the incidence of chromosomal abnormalities in patients with high-risk breast cancer (HRBC) after high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT), and correlated the cytogenetic abnormalities with the development of post-transplant myelodysplastic syndrome or acute myeloid leukemia (MDS/AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286182.RA9o8U51TqTKc92-NouuUGEgRY1BMKA6N9XC_5Cl4EZSE130_provenance.